Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-06 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |